← FDA Drug Approvals (Drugs@FDA)

MIRVASO

NDA · New Drug Application · Sponsor: GALDERMA LABS LP · Approved 2013-08-23

Drug application

FDA Application #

NDA204708

Application type

New Drug Application

Brand name

MIRVASO

Generic name

BRIMONIDINE TARTRATE

Active ingredients

BRIMONIDINE TARTRATE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

GALDERMA LABS LP

Manufacturer

Galderma Laboratories, L.P.

First approval

2013-08-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown